Powel Brown

Powel Brown

UNVERIFIED PROFILE

Are you Powel Brown?   Register this Author

Register author
Powel Brown

Powel Brown

Publications by authors named "Powel Brown"

Are you Powel Brown?   Register this Author

100Publications

1843Reads

16Profile Views

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression.

NPJ Breast Cancer 2019 26;5:22. Epub 2019 Jul 26.

1Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-019-0118-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659706PMC
July 2019

NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question.

J Natl Cancer Inst 2018 09;110(9):927-928

Division of Cancer Prevention and Population Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136929PMC
September 2018

A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer .

Cancer Prev Res (Phila) 2018 05 4;11(5):295-302. Epub 2018 Apr 4.

Department of Clinical Cancer Prevention, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-17-0314DOI Listing
May 2018

Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.

DNA Repair (Amst) 2017 12 24;60:89-101. Epub 2017 Oct 24.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dnarep.2017.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909195PMC
December 2017

Molecularly targeted therapies for p53-mutant cancers.

Cell Mol Life Sci 2017 11 22;74(22):4171-4187. Epub 2017 Jun 22.

Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit Number: 1360, Room Number: CPB6.3468, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-017-2575-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664959PMC
November 2017

Identifying Cell Cycle Modulators That Selectively Target ARID1A Deficiency Using High-Throughput Image-Based Screening.

SLAS Discov 2017 08 15;22(7):813-826. Epub 2017 Mar 15.

2 Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2472555217698942DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921049PMC
August 2017

Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.

Clin Cancer Res 2017 May 13;23(9):2136-2142. Epub 2017 Jan 13.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0934DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413367PMC
May 2017

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.

Mol Cancer Res 2016 05 10;14(5):470-81. Epub 2016 Mar 10.

Lester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. Department of Medicine, Baylor College of Medicine, Houston, Texas. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-15-0423DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867274PMC
May 2016

Strategies of hormonal prevention.

Cancer Treat Res 2009 ;147:1-35

, .

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-0-387-09463-2_10
Publisher Site
http://dx.doi.org/10.1007/978-0-387-09463-2_10DOI Listing
April 2016

Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.

Cancer Res 2016 04 26;76(7):1942-53. Epub 2016 Feb 26.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0673DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873402PMC
April 2016

Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Semin Oncol 2016 Feb 25;43(1):49-64. Epub 2015 Sep 25.

Department of Clinical Cancer Prevention, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789177PMC
February 2016

Women's Expectations for Breast Cancer Prevention and Early Detection: High Expectations Can Be Achieved.

Authors:
Powel Brown

Oncologist 2016 Jan 16;21(1):4-6. Epub 2015 Dec 16.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709217PMC
January 2016

Molecular cancer prevention: Current status and future directions.

CA Cancer J Clin 2015 Sep-Oct;65(5):345-83. Epub 2015 Aug 18.

Vice President and Division Head, Boone Pickens Distinguished Chair for Early Prevention of Cancer, Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820069PMC
December 2015

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.

Cancer Discov 2015 Jul 11;5(7):752-67. Epub 2015 Jun 11.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Medical Oncology, Tongji Hospital, Tongji Medical College, The Huazhong University of Science and Technology, Wuhan, P.R. China.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/cgi/doi/10.1158/2159
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-14-0849DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497871PMC
July 2015

TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth.

Proc Natl Acad Sci U S A 2015 Jun 10;112(25):E3216-25. Epub 2015 Jun 10.

Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1420811112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485113PMC
June 2015

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.

Lancet Oncol 2014 Dec 24;15(13):e625-e634. Epub 2014 Nov 24.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70364-XDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413447PMC
December 2014

AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.

Breast Cancer Res Treat 2014 Oct 2;147(3):473-85. Epub 2014 Sep 2.

Lester and Sue Smith Breast Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3082-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337991PMC
October 2014

Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.

Breast Cancer Res Treat 2014 Jul 18;146(1):211-20. Epub 2014 May 18.

Department of Clinical Cancer Prevention, Unit 1360, The University of Texas M.D. Anderson Cancer Center, P.O. Box 301439, Houston, TX, 77030-1439, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2991-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061465PMC
July 2014

Prevention: targeted therapy-anastrozole prevents breast cancer.

Authors:
Powel Brown

Nat Rev Clin Oncol 2014 Mar 18;11(3):127-8. Epub 2014 Feb 18.

Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.17DOI Listing
March 2014

Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer.

Curr Breast Cancer Rep 2014 ;6:96-109

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1155 Herman P. Pressler, Unit 1360, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12609-014-0144-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015058PMC
January 2014

Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy.

Cell Cycle 2013 Sep 30;12(17):2705-6. Epub 2013 Jul 30.

Department of Clinical Cancer Prevention; The University of Texas MD Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.25871DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899176PMC
September 2013

Targeted therapy for breast cancer prevention.

Front Oncol 2013 Sep 23;3:250. Epub 2013 Sep 23.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780469PMC
September 2013

Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.

Cancer Prev Res (Phila) 2013 Jul 16;6(7):646-55. Epub 2013 May 16.

Department of Surgery (Head and Neck Service), Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-13-0083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707304PMC
July 2013

The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.

Cancer Prev Res (Phila) 2012 Oct 27;5(10):1195-202. Epub 2012 Aug 27.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837417PMC
October 2012

Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.

Nat Rev Gastroenterol Hepatol 2012 Sep 19;9(9):530-8. Epub 2012 Jun 19.

Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2012.114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745216PMC
September 2012

A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers.

Contemp Clin Trials 2012 Sep 5;33(5):942-8. Epub 2012 Jul 5.

Department of Surgery (Head and Neck Service), Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15517144120017
Publisher Site
http://dx.doi.org/10.1016/j.cct.2012.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460548PMC
September 2012

SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).

Breast Cancer Res Treat 2012 Jul 3;134(1):101-15. Epub 2012 Jan 3.

Department of Clinical Cancer Prevention, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1925-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416040PMC
July 2012

The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.

Breast Cancer Res Treat 2012 Jun 24;133(2):487-500. Epub 2011 Sep 24.

Department of Clinical Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1775-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424514PMC
June 2012

Aromatase inhibitors and breast cancer prevention.

Expert Opin Pharmacother 2012 Feb 14;13(3):325-31. Epub 2012 Jan 14.

The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology , 1515 Holcombe Boulevard, Unit 1354, Houston, TX 77030 , USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.2012.65
Publisher Site
http://dx.doi.org/10.1517/14656566.2012.651459DOI Listing
February 2012

Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.

Mol Endocrinol 2011 Sep 11;25(9):1527-38. Epub 2011 Aug 11.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2011-1037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165912PMC
September 2011

The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor.

Breast Cancer Res Treat 2011 Aug 7;128(3):667-77. Epub 2010 Sep 7.

Department of Clinical Cancer Prevention, The University of Texas, Anderson Cancer Center Cancer, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-010-1083-9
Publisher Site
http://dx.doi.org/10.1007/s10549-010-1083-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444826PMC
August 2011

Targeting the HER/EGFR/ErbB family to prevent breast cancer.

Cancer Prev Res (Phila) 2011 Aug;4(8):1149-57

Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0334DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171200PMC
August 2011

A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.

BMC Cancer 2011 Aug 25;11:377. Epub 2011 Aug 25.

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-11-377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189189PMC
August 2011

Preventive therapy for breast cancer: a consensus statement.

Lancet Oncol 2011 May;12(5):496-503

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(11)70030-4DOI Listing
May 2011

Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.

Recent Results Cancer Res 2011 ;188:147-62

Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-10858-7_13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415693PMC
March 2011

Tumor-suppressor activity of RRIG1 in breast cancer.

BMC Cancer 2011 Jan 25;11:32. Epub 2011 Jan 25.

Department of Clinical Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/1471-240
Publisher Site
http://dx.doi.org/10.1186/1471-2407-11-32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037341PMC
January 2011

Drug development for cancer chemoprevention: focus on molecular targets.

Semin Oncol 2010 Aug;37(4):345-58

Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2010.05.012DOI Listing
August 2010

Two good choices to prevent breast cancer: great taste, less filling.

Cancer Prev Res (Phila) 2010 Jun;3(6):681-5

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-10-0101DOI Listing
June 2010

Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.

Cancer Res 2009 Dec 17;69(23):8853-61. Epub 2009 Nov 17.

Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830975PMC
December 2009

A novel look into estrogen receptor-negative breast cancer prevention with the natural, multifunctional signal transduction inhibitor deguelin.

Cancer Prev Res (Phila) 2009 Nov 27;2(11):915-8. Epub 2009 Oct 27.

Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0208DOI Listing
November 2009

Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer.

Clin Cancer Res 2009 Oct 6;15(20):6327-40. Epub 2009 Oct 6.

Department of Molecular and Cellular Biology, Lester and Sue Smith Breast Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763053PMC
October 2009

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Lancet Oncol 2009 May;10(5):501-7

Cancer Research UK Centre for Epidemiology, Mathematics, and Statistics, Queen Mary University of London, London UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70035-XDOI Listing
May 2009

Prevention of ER-negative breast cancer.

Recent Results Cancer Res 2009 ;181:121-34

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068124PMC
http://dx.doi.org/10.1007/978-3-540-69297-3_13DOI Listing
March 2009

Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.

Cancer Prev Res (Phila) 2009 Feb 27;2(2):168-74. Epub 2009 Jan 27.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995265PMC
February 2009

Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.

Cancer Prev Res (Phila) 2009 Feb 27;2(2):175-84. Epub 2009 Jan 27.

Department of Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023963PMC
February 2009

Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.

J Biol Chem 2009 Jan 28;284(1):345-53. Epub 2008 Oct 28.

Breast Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M804721200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610495PMC
January 2009

Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.

J Natl Cancer Inst 2009 Jan 13;101(2):107-13. Epub 2009 Jan 13.

Breast Center, Department of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djn436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639315PMC
January 2009

Breast cancer prevention using calcium and vitamin D: a bright future?

J Natl Cancer Inst 2008 Nov 11;100(22):1562-4. Epub 2008 Nov 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djn390DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299212PMC
November 2008

Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.

BMC Med Genomics 2008 Sep 11;1:40. Epub 2008 Sep 11.

Department of Carcinogenesis, The University of Texas M,D, Anderson Cancer Center, Science Park-Research Division, Smithville, 78957, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-8794-1-40DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563021PMC
September 2008

The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges.

Cancer Prev Res (Phila) 2008 Aug;1(3):161-6

Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758098PMC
August 2008

Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth.

Mol Cell Endocrinol 2007 Oct 19;277(1-2):13-25. Epub 2007 Jul 19.

Department of Molecular and Cellular Biology, and Breast Center, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2007.07.006DOI Listing
October 2007

Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention Research.

Cancer Res 2007 Oct 25;67(19):8989-93. Epub 2007 Sep 25.

Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-3171DOI Listing
October 2007

Chemoprevention clinical trials: it is time to turn success into progress.

Authors:
Powel H Brown

Cancer Epidemiol Biomarkers Prev 2007 Aug;16(8):1531-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-07-0594DOI Listing
August 2007

Translational approaches for the prevention of estrogen receptor-negative breast cancer.

Eur J Cancer Prev 2007 Jun;16(3):203-15

Departments of Medicine and Molecular and Cellular Biology, Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CEJ.0b013e328011ed98DOI Listing
June 2007

Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.

Breast Cancer Res 2007 ;9(1):R12

Department of Pathology, Texas Tech University Health Sciences Center, 4800 Alberta Avenue, El Paso, TX 79905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1645DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851398PMC
May 2007

Inducible overexpression of c-Jun in MCF7 cells causes resistance to vinblastine via inhibition of drug-induced apoptosis and senescence at a step subsequent to mitotic arrest.

Biochem Pharmacol 2007 Feb 29;73(4):481-90. Epub 2006 Oct 29.

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Mail Slot 516, 4301 W. Markham Street, Little Rock, AR 72205, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2006.10.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829171PMC
February 2007

Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway.

J Biol Chem 2007 Feb 11;282(6):3507-19. Epub 2006 Dec 11.

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M D Anderson Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M610141200DOI Listing
February 2007

Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.

Cancer Lett 2006 Dec 8;244(2):203-10. Epub 2006 Feb 8.

Department of Pathology, College of Medicine, Hanyang University, 17 Haengdang-dang, Seongdong-Gu, Seoul 133-791, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2005.12.016DOI Listing
December 2006

Prevention of breast cancer: current state of the science and future opportunities.

Expert Opin Investig Drugs 2006 Dec;15(12):1583-600

Breast Care Center, Department of Medicine, Baylor College of Medicine, Methodist Hospital, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.15.12.1583DOI Listing
December 2006

Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha.

Breast Cancer Res Treat 2006 Sep 16;99(2):121-34. Epub 2006 Mar 16.

Department of Medicine, Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-006-9191-2
Publisher Site
http://dx.doi.org/10.1007/s10549-006-9191-2DOI Listing
September 2006

The AP-1 transcription factor regulates postnatal mammary gland development.

Dev Biol 2006 Jul 4;295(2):589-603. Epub 2006 Apr 4.

Breast Center, Baylor College of Medicine, MS600, 1 Baylor Plaza, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ydbio.2006.03.042DOI Listing
July 2006

Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.

Biochem J 2006 May;395(3):653-62

Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BJ20051794DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462695PMC
May 2006

Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.

Cancer Res 2006 May;66(10):5304-13

Breast Center, Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-2858DOI Listing
May 2006

Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.

Breast Cancer Res Treat 2006 Mar 5;96(2):147-57. Epub 2005 Nov 5.

Department of Medicine and Molecular and Cellular Biology, Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-9071-1DOI Listing
March 2006